Acadian Asset Management’s Globus Medical GMED Stock Holding History

Acadian Asset Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$454K	Sell	5,773 -4,481	-44%	-$381K	﹤0.01%	1479
2026 Q1	$878K	Buy	+10,254	New	+$920K	﹤0.01%	1202
2021 Q3	–	Sell	-1,447	Closed	-$112K	–	1828
2021 Q2	$112K	Buy	+1,447	New	+$103K	﹤0.01%	1608
2018 Q4	–	Sell	-14,601	Closed	-$829K	–	1759
2018 Q3	$829K	Buy	+14,601	New	+$768K	﹤0.01%	777
2016 Q2	–	Sell	-397	Closed	-$10K	–	1454
2016 Q1	$10K	Buy	+397	New	+$9.71K	﹤0.01%	1194

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.25% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Acadian Asset Management's GMED Position: Q2 2026 in Review

Acadian Asset Management reduced its Globus Medical (GMED) stake by 44% in Q2 2026, selling an estimated $381K and leaving 5,773 shares worth $454K. The position accounts for ﹤0.01% of the portfolio, ranked #1479.

Acadian Asset Management first reported a position in GMED in Q1 2016 and has held it in 5 quarters since. The position peaked at $878K in Q1 2026. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Acadian Asset Management held 5,773 shares of Globus Medical worth $454K as of Q2 2026.
Acadian Asset Management sold 4,481 Globus Medical shares in Q2 2026, an estimated $381K.
Globus Medical made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1479 holding.
Acadian Asset Management first reported a position in Globus Medical in Q1 2016 and has held it in 5 quarters since.
Acadian Asset Management's Globus Medical position peaked at $878K in Q1 2026.
601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.